Will Surgery Be Disappeared From The Treatment Of Breast Cancer?

Remy Salmon (1)
(1) M.D., Emeritus Professor, Department of Surgery, Curie Institute, Paris, France, France



Full text article

Generated from XML file


Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022 ;66:15-23. doi: 10.1016/j.breast.2022.08.010.

Sun S, van la Parra RFD, Rauch GM, Checka C, Tadros AB, Lucci A Jr, et al. Patient Selection for Clinical Trials Eliminating Surgery for HER2-Positive Breast Cancer Treated with Neoadjuvant Systemic Therapy. Ann Surg Oncol. 2019 ;26(10):3071-3079. doi: 10.1245/s10434-019-07533-2.

Barron AU, Hoskin TL, Day CN, Hwang ES, Kuerer HM, Boughey JC. Association of Low Nodal Positivity Rate Among Patients With ERBB2-Positive or Triple-Negative Breast Cancer and Breast Pathologic Complete Response to Neoadjuvant Chemotherapy. JAMA Surg. 2018. 1;153(12):1120-1126. doi: 10.1001/jamasurg.2018.2696.

Sugita BM, Pereira SR, de Almeida RC, Gill M, Mahajan A, Duttargi A, et al. Integrated copy number and miRNA expression analysis in triple negative breast cancer of Latin American patients. Oncotarget. 2019. 22;10(58):6184-6203. doi: 10.18632/oncotarget.27250.

Chassin JL. Modified Radical Mastectomy (Patey). In: Operative Strategy in General Surgery. Springer, 1984, New York, NY. doi: 10.1007/978-1-4757-4172-8_3.

Madden JL, Kandalaft S, Bourque RA. Modified radical mastectomy. Ann Surg. 1972 May;175(5):624–634.

J. Boyages and L. Baker. Evolution of radiotherapy techniques in breast conservation treatment. Gland Surgery; Vol 7, No 6: Gland Surgery (Breast Conservation Surgery) 2018. doi: 10.21037/gs.2018.11.10.

Jacquillat C, Weil M, Auclerc G, Auclerc MF, Khayat D, Baillet F. (1989). Neoadjuvant Chemotherapy in the Conservative Management of Breast Cancer: A Study of 252 Patients. In: Senn, HJ., Goldhirsch, A., Gelber, R.D., Osterwalder, B. (eds) Adjuvant Therapy of Primary Breast Cancer. Recent Results in Cancer Research, vol 115. Springer, Berlin, Heidelberg. doi:10.1007/978-3-642-83337-3_6.

First person profile: Monica Morrow, MD: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology: The chief of the Breast Service at Memorial Sloan Kettering Cancer Center (MSKCC) has made a lasting impact on breast surgical oncology. Cancer. 2022. 1;128(15):2850-2851. doi: 10.1002/cncr.34362.

Aznab M, Shojae S, Golpazir Sorkheh A, Eslam pia K, Rezaei M. The Survival of Patients with Triple Negative Breast Cancer Undergoing Chemotherapy Along with Lifestyle Change Interventions: Survival of TNBC patients. Arch Breast Cancer. 2022. 10(1):66-73 doi : 10.32768/abc.202310166-73

Budiarta M, Brennan M. The Impact of COVID-19 on Breast Cancer Treatment: A Systematic Review: Breast cancer treatment during pandemic. Arch Breast Cancer [Internet]. 2022 Jul. 30. 14];9(4):421-38. Doi : 10.32768/abc.202294421-438

Abdollahi J, Davari N, Panahi Y, Gardaneh M. Detection of Metastatic Breast Cancer from Whole-Slide Pathology Images Using an Ensemble Deep-Learning Method: Detection of Breast Cancer using Deep-Learning. Arch Breast Cancer. 2022. 13 [cited 2023 Apr. 14];9(3):364-76

Dinnes J, Ferrante di Ruffano L, Takwoingi Y, Cheung ST, Nathan P, et al; Cochrane Skin Cancer Diagnostic Test Accuracy Group. Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma. Cochrane Database Syst Rev. 2019. 1;7(7):CD012806. doi: 10.1002/14651858.CD012806.pub2.


Remy Salmon
dr.rjsalmon@gmail.com (Primary Contact)
Salmon R. Will Surgery Be Disappeared From The Treatment Of Breast Cancer?. Arch Breast Cancer [Internet]. 2023 Apr. 17 [cited 2024 May 23];10(2):99-102. Available from: https://archbreastcancer.com/index.php/abc/article/view/706

Article Details

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.